Waters Corporation
WATHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Waters Corporation focuses on Diagnostics & Research services and products. Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. At a $36.52B market cap, Waters Corporation ranks as a large-cap company within healthcare. The company operates through two segments, Waters and TA.
Market Cap
$36.52B
Beta
1.14
P/E (TTM)
47.26
P/E (Fwd)
22.61
EPS (TTM)
$7.87
EPS (Fwd)
$16.45
ROE
5.2%
ROA
3.3%
Cash
$462.0M
Total Debt
$5.60B
Free CF
-$502.4M
52W Change
5.3%
Annual Financials
Cash vs Debt
On the balance sheet, WAT has $462.0M in cash with $5.60B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$502.4M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of 5.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.97B (2022) to $3.17B (2025).
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing WAT.